Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation

Sepsis-induced myocardial dysfunction (SIMD) is a fatal disease with no specific treatment worldwide to this day. As a biological product, platelet-rich plasma (PRP) has attracted much attention due to its diverse and potential biological effects. However, its role in lipopolysaccharide (LPS)-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Yuheng, Zhang, Qingyu, Zhang, Jiayan, Zha, Yafang, Wang, Jian, Li, Yanyan, Zhang, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623117/
https://www.ncbi.nlm.nih.gov/pubmed/36330090
http://dx.doi.org/10.3389/fphar.2022.1026641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623117/
https://www.ncbi.nlm.nih.gov/pubmed/36330090
http://dx.doi.org/10.3389/fphar.2022.1026641

Ejemplares similares